Your browser doesn't support javascript.
loading
Faecal calprotectin as a potential biomarker of disease severity in SARS-CoV-2 infection.
O'Moráin, N; Stack, R; Doherty, J; Tosetto, M; Garcia Leon, A; Mallon, P; Doherty, G.
Afiliación
  • O'Moráin N; Centre for Colorectal Disease, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland; School of Medicine, University College Dublin, Dublin, 4, Ireland. Electronic address: neilomorain@svhg.ie.
  • Stack R; Centre for Colorectal Disease, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland; School of Medicine, University College Dublin, Dublin, 4, Ireland.
  • Doherty J; Centre for Colorectal Disease, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland; School of Medicine, University College Dublin, Dublin, 4, Ireland.
  • Tosetto M; Centre for Colorectal Disease, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland.
  • Garcia Leon A; Centre for Experimental Pathogen Host Research, University College Dublin, Dublin, 4, Ireland.
  • Mallon P; Centre for Experimental Pathogen Host Research, University College Dublin, Dublin, 4, Ireland; Department of Infectious Disease, St. Vincent's University Hospital, Dublin, 4, Ireland.
  • Doherty G; Centre for Colorectal Disease, St. Vincent's University Hospital, Elm Park, Dublin 4, Ireland; School of Medicine, University College Dublin, Dublin, 4, Ireland.
J Infect ; 85(4): 436-480, 2022 10.
Article en En | MEDLINE | ID: mdl-35768051

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Complejo de Antígeno L1 de Leucocito / COVID-19 Idioma: En Revista: J Infect Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Complejo de Antígeno L1 de Leucocito / COVID-19 Idioma: En Revista: J Infect Año: 2022 Tipo del documento: Article